NEW YORK (TheStreet) -- Shares of Medidata Solutions (MDSO) - Get Medidata Solutions, Inc. Report were falling 7.1% to $40 Tuesday after missing analysts' estimates for revenue and lowering its full year guidance.

The healthcare information services company reported earnings of 20 cents a share, in-line with the Capital IQ Consensus Estimate of 20 cents a share. Revenue rose 21.3% year over year to $86 million for the quarter, below analysts' estimates of $87.72 million.

Medidata Solutions lowered its full year 2014 revenue guidance to between $335 million and $340 million from between $340 million and $345 million for the full year. Analysts expect revenue of $342.03 million for the year.

Must Read:Warren Buffett's 25 Favorite Stocks

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreet Recommends

TheStreet Ratings team rates MEDIDATA SOLUTIONS INC as a Hold with a ratings score of C. TheStreet Ratings Team has this to say about their recommendation:

"We rate MEDIDATA SOLUTIONS INC (MDSO) a HOLD. The primary factors that have impacted our rating are mixed -- some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its robust revenue growth and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow."

You can view the full analysis from the report here: MDSO Ratings Report

MDSO data by YCharts

Image placeholder title

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.